Quillaia Extract - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The quillaia extract market size is expected to grow from USD 323.64 million in 2025 to USD 349.85 million in 2026 and is forecast to reach USD 516.29 million by 2031 at 8.10% CAGR over 2026-2031. This report is Segmented by Form (Powder and Liquid), by Application (Food and Beverage, Pharmaceutical, Personal Care and Cosmetic, Animal Feed, and Others), and by Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Quillaia Extract Market Trends and Insights

Rising Demand for Natural Foaming Agents in Beverages

The beverage industry is experiencing a significant transition toward natural foaming agents, primarily driven by consumer demand for reduced synthetic additives and regulatory requirements. The molecular composition of quillaia extract, comprising both hydrophobic and hydrophilic elements, demonstrates superior foam stability characteristics compared to synthetic alternatives such as Tween 80, establishing its position as the preferred component in premium beverage formulations. Major beverage manufacturers are implementing product reformulations to comply with clean-label requirements, resulting in increased utilization of quillaja saponins in beverages. The Food and Drug Administration (FDA) approval of natural color additives, specifically butterfly pea flower extract in May 2025, demonstrates enhanced regulatory acceptance of natural ingredients, facilitating the implementation of quillaia extract

Increasing Usage in Animal Health and Feed Additives

The animal feed market shows significant growth potential for quillaia extract applications, driven by the industry's shift from antibiotic growth promoters to natural performance enhancers that support animal health and ensure food safety. The European Food Safety Authority's approval of Magni-PHI (containing 85% Quillaja saponaria and 15% Yucca schidigera) for all poultry species in July 2024 confirms the safety and efficacy of quillaja-based feed additives at a concentration of 250 mg/kg in complete feed, as per EFSA. This regulatory approval creates market opportunities, as the global animal feed industry increases its focus on natural additives that improve nutrient absorption and immune function. The antimicrobial properties of Quillaja saponins against pathogenic fungi and their function as natural immunoadjuvants make them effective solutions for livestock production, especially in regions with strict antibiotic regulations.

Potential Toxicity at High Concentrations

The hemolytic properties of quillaia extract at high concentrations present formulation challenges that limit its applications and necessitate precise dosage control across product categories. The European Food Safety Authority's re-evaluation established safety parameters, including an acceptable daily intake of 3 mg saponins per kg body weight per day, derived from a NOAEL of 1,500 mg/kg body weight per day in toxicological studies. In pharmaceutical applications, QS-21's membranolytic effects require precise formulation to balance vaccine adjuvant benefits against potential adverse reactions. Due to these membranolytic concerns in parenteral use, alternative delivery systems such as Immunostimulating Complexes (ISCOMs) have been developed to maintain adjuvant properties without hemolytic activity at standard doses. These technical requirements drive advancements in formulation and delivery systems, benefiting companies that can develop safer and effective quillaia-based products.

Other drivers and restraints analyzed in the detailed report include:

• Growing Consumer Shift Towards Plant-Based Ingredients
• Utilization in Herbal and Functional Beverages
• Regulatory Restrictions on Maximum Usage Limits

Segment Analysis

Powder form quillaia extract holds 63.78% market share in 2025, due to established manufacturing processes and cost advantages in traditional applications across food, pharmaceutical, and cosmetic industries. The powder form offers stability, extended shelf life, and efficient transportation, providing economic benefits for manufacturers with global supply chains, especially in price-sensitive markets. Liquid quillaia extract, while holding a smaller market share, is projected to grow at 9.41% CAGR through 2031, driven by its enhanced bioavailability and integration capabilities in modern formulations.

The industry's adoption of advanced extraction technologies supports liquid formulations, as supercritical CO2 extraction and other environmentally conscious methods produce high-quality liquid extracts for specialized applications. The 2024 Path2Green framework promotes sustainable extraction methods that typically result in liquid concentrates with enhanced functional properties compared to conventional powder processing. While the powder segment maintains its market leadership through established supply chains and market maturity, the liquid segment's growth indicates a shift toward advanced formulation technologies and higher-value applications.

Complete Report Scope:

• By Form
  • Powder
  • Liquid
• By Application
  • Food and Beverage
    • Bakery and Confectionary
    • Dairy and Dairy Products
    • Beverage
    • Others
  • Pharmaceutical
  • Personal Care and Cosmetic
  • Animal Feed
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

Europe holds 34.05% market share in 2025, driven by robust regulatory frameworks supporting natural ingredients and advanced pharmaceutical manufacturing capabilities. Germany, France, and the United Kingdom show significant demand for natural food additives and pharmaceutical ingredients. The European Union's Novel Foods Regulation facilitates botanical ingredient approval, while regional sustainability priorities support market growth due to quillaia extract's natural and biodegradable characteristics.

Asia-Pacific exhibits the highest growth rate at 9.60% CAGR through 2031. This growth stems from expanding functional beverage markets, increased regulatory acceptance of natural food additives, and enhanced pharmaceutical manufacturing capabilities in China, Japan, and India. China's State Administration for Market Regulation's October 2024 expansion of health food registration to include beverages, chocolates, and candies creates new opportunities for quillaia extract. The region benefits from traditional acceptance of herbal medicine, growing middle-class populations, and established regulatory frameworks, including Japan's Food Additives Association and Australia-New Zealand's Food Standards Australia New Zealand (FSANZ) guidelines.

North America maintains a significant market position due to FDA GRAS status for quillaia extract and consumer preference for natural ingredients in food, pharmaceutical, and cosmetic applications. The United States represents the largest single-country market globally, supported by biotechnology investments and sustainable extraction technology development. Canada's natural products industry and Mexico's manufacturing capabilities contribute to regional growth. South America, particularly Chile, maintains a crucial role in global supply chains as the primary raw material source. The Middle East and Africa show emerging market potential as their regulatory frameworks and consumer awareness develop, particularly in countries with established pharmaceutical and food processing sectors.

List of Companies Covered in this Report:

• Garuda International, Inc.
• Givaudan SA
• Ingredion Incorporated
• Baja Yucca Company
• Quillaja Green Biosolutions
• Plantae Labs
• Nexira SAS
• Desert King International
• Kerry Group plc
• Ataman Kimya A.S
• Chile Botanics S.A.
• Jiaherb Inc.
• Shaanxi Pioneer Biotech Co., Ltd.
• Taylor & Francis Group
• Undersun Biomedtech Corp.
• Madhu Chemicals
• Adams Food Ingredients Ltd
• Bioway Organic Ingredients Co.,Ltd
• Xi'an Haoze Biotechnology Co., Ltd.
• Synthite Industries Ltd

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support